<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02111837</url>
  </required_header>
  <id_info>
    <org_study_id>07.16.INF.B</org_study_id>
    <nct_id>NCT02111837</nct_id>
  </id_info>
  <brief_title>Effects of Specific Lipid Fractions-enriched Infant Formulae</brief_title>
  <official_title>Multicenter, Randomized, Double-blind, Parallel-group, Reference-controlled, Safety Pilot Study to Evaluate the Effects of Specific Lipid Fractions-enriched Infant Formulae in Infants Aged 0-4 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, randomized, double-blind, parallel-group, reference-controlled 4-month
      pilot safety study to evaluate the effects of specific lipid fractions-enriched infant
      formulae on growth of infants aged 0-4 months. The study will test the hypothesis that growth
      of infants fed the specific lipid fractions-enriched infant formulae will be noninferior to
      growth of infants fed standard infant formula.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean weight gain (g/day)</measure>
    <time_frame>Enrollment to age 4 months</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">199</enrollment>
  <condition>Infant Growth</condition>
  <arm_group>
    <arm_group_label>Standard infant formula</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard infant formula fed ad libitum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard infant formula with PL1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard infant formula enriched with PL1 lipid fraction fed ad libitum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard infant formula with PL2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard infant formula enriched with PL2 lipid fraction fed ad libitum</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard infant formula</intervention_name>
    <arm_group_label>Standard infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard infant formula with PL1</intervention_name>
    <arm_group_label>Standard infant formula with PL1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard infant formula with PL2</intervention_name>
    <arm_group_label>Standard infant formula with PL2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy newborn infant

          -  Infant is ≤14 days old on day of enrollment

          -  Gestational age ≥37 weeks (full term infants)

          -  Birth weight ≥2500 g and ≤4500 g

          -  Singleton birth

          -  Having obtained his/her parents'/legal representative's informed consent

        Exclusion Criteria:

          -  Having any significant pre-natal and/or post-natal disease and/or congenital illness
             or malformation that may affect normal growth.

          -  Infant undergoing antibiotic therapy.

          -  Re-hospitalization for more than 2 days in the first 14 days of life.

          -  Parents not expected to comply with the protocol during the period of study
             participation.

          -  Infants currently participating in another trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claude Billeaud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital des enfants, CHU Pellegrin, Bordeaux, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <state>Cedex 9</state>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Bretonneau - UPM</name>
      <address>
        <city>Tours</city>
        <state>Cedex 9</state>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto di Ostetricia e Ginecologia Neonatalogia</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2014</study_first_submitted>
  <study_first_submitted_qc>April 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2014</study_first_posted>
  <last_update_submitted>April 9, 2014</last_update_submitted>
  <last_update_submitted_qc>April 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

